Wolf John Peter III

Avg. Two Year Performance

No purchase track record
(30%) Avg. Sale Return
(14%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(18%)(4%)(70%)(30%)
Sale Success Rate1 of 20 of 21 of 20 of 20 of 2
Drugs » Biotechnology

General Counsel:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

VP, General Counsel:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

General Counsel and Corp. Sec.:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--